News
With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...
Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical ...
Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.
Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule ...
Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Sapterna (SEPN) for obesity pills.
Novo Nordisk partners with U.S. biotech Septerna in a $2.2 billion deal to develop oral small molecule drugs for obesity and ...
20h
Verywell Health on MSNCould Wegovy Cause Hair Loss?People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...
6h
InvestorsHub on MSNNovo Nordisk Inks $2.2 Billion Deal with Septerna to Advance Obesity and Diabetes TreatmentsNovo Nordisk (NYSE: NVO) has entered into a collaboration and licensing agreement with U.S.-based biotech firm Septerna ...
19h
Health on MSNWhy You Might Tolerate One Weight Loss Drug Better Than Another, According to ExpertsFact checked by Nick Blackmer Tirzepatide and semaglutide, the ingredients in popular weight loss drugs, can both cause side ...
Ozempic side effects are a hot topic but don’t panic – our experts are here to help. Here’s what to expect and how to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results